What Makes a Pancreatic Cancer Resectable?

Area of Science:

• Oncology
• Surgical Oncology
• Gastroenterology

Background:

• Surgery alone is insufficient for localized pancreatic cancer cure, as most patients develop metastases.
• Micrometastases are often present at diagnosis, necessitating systemic therapy before or after surgery.
• Current treatment paradigms are shifting towards early systemic therapy followed by surgery.

Purpose of the Study:

• To define criteria for surgical operability in pancreatic cancer.
• To guide the timing and patient selection for pancreatic cancer surgery.
• To provide a comprehensive overview of when surgery is indicated for pancreatic cancer.

Main Methods:

• Review of current literature and treatment guidelines.
• Analysis of factors influencing surgical decision-making in pancreatic cancer.
• Discussion of tumor anatomy and patient-specific factors for operability.

Main Results:

• Surgery alone is inadequate for cure in most pancreatic cancer cases.
• Systemic therapy followed by surgery is increasingly favored for operable patients.
• Consensus is lacking on precise operability definitions and surgical center volume.

Conclusions:

• Optimal pancreatic cancer treatment requires careful consideration of systemic therapy and surgical timing.
• Defining operability is crucial for stage-specific therapy and patient outcome expectations.
• Further consensus is needed on operability criteria and surgical expertise for pancreatic cancer operations.